fbpx

Now Available: Our 2023 State of Patient Empowerment Report Learn more >>

Get FDA-approved guidance for your non-metastatic stage 3 breast cancer

The free cancer app that helps patients manage their care.

Download Outcomes4Me free:

Suzanne Garner
Cancer Survivor, Outcomes4Me User

Evidence-based.
Oncologist-approved.

We’re the only non-metastatic stage 3 breast cancer app that integrates with the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), from the not-for-profit alliance of 33 leading cancer centers. The NCCN Guidelines® include comprehensive guidance related to all FDA-approved treatment options.

We gather non-metastatic stage 3 breast cancer treatment recommendations typically meant for oncologists and use Artificial Intelligence (AI) to translate that information so you can understand it, putting you in control. With this knowledge, you can feel empowered to make the best medical decisions with your care team.

No matter your breast cancer diagnosis,
you deserve to be in control.

With our free breast cancer app, you’ll get:

  • Personalized non-metastatic stage 3 breast cancer treatment options
  • Genetic and genomic testing opportunities
  • Symptom tracking and management
  • Access to the latest innovation and clinical trials
  • Health records you can understand
  • A peer community
We’re here because you’re here.
For Breast Cancer
Patients

Gain direct access to personalized treatment options so you can have more informed conversations with your care team.

For Oncology
Care Providers

Rely on us to help your patients get access to the best non-metastatic stage 3 breast cancer care and resources, and save time in your day. We’re here to help and won’t ever get in the way.

For Life
Sciences

Accelerate patient access to your treatments and expand the reach of your non-metastatic stage 3 breast cancer research and clinical trials.

Self-advocacy
comes first here.

Get all the information you need to take a more active role in treating your non-metastatic stage 3 breast cancer.

Collaborating with experts in non-metastatic stage 3 breast cancer
care all over the world.

Frequently Asked Questions

How long can you live with stage 3 breast cancer?

The 5-year relative survival rate for Stage 3 breast cancer is around 72%. This means that, on average, about 72% of people with Stage 3 breast cancer are expected to live at least five years after their diagnosis.

According to the NCCN guidelines, adjuvant chemotherapy is generally recommended for most patients with Stage 3 breast cancer. 

The National Comprehensive Cancer Network (NCCN) provides guidelines for breast cancer treatment, and these guidelines are based on the latest evidence and expert consensus. 

The decision to recommend chemotherapy for Stage 3 breast cancer depends on various factors, including the specific characteristics of the cancer, the presence of certain biomarkers, and individual health considerations. In most cases of Stage 3 breast cancer, chemotherapy is a standard part of the treatment plan, especially if the cancer is more aggressive or has a higher risk of recurrence.

Recovery from Stage 3 breast cancer is possible, and many individuals with this stage of cancer go on to live healthy and fulfilling lives after successful treatment. However, it’s essential to note that the likelihood of recovery and long-term survival depends on various factors, including the specific characteristics of the cancer, the effectiveness of the treatment, and individual patient factors.

The American Cancer Society provides information on breast cancer survival rates, including for Stage 3 breast cancer. While the 5-year relative survival rate for Stage 3 breast cancer is around 72%, it’s important to understand that survival rates are statistical estimates and don’t predict the outcome for any individual case. Many people live well beyond the 5-year mark, and advances in treatment continue to improve outcomes.

Stage 3 breast cancer is considered an advanced stage, and the extent of the disease can vary within this stage. In general, Stage 3 breast cancer indicates that the cancer has spread beyond the breast and nearby lymph nodes to surrounding tissues. The prognosis for Stage 3 breast cancer can be challenging, but outcomes vary widely based on individual factors and advancements in treatment.

According to the American Cancer Society, the 5-year relative survival rate for Stage 3 breast cancer is around 72%. This statistic indicates the percentage of people with the same type and stage of cancer who are alive five years after diagnosis. It’s important to note that survival rates are estimates and do not predict individual outcomes.

Yes, the survival rates for Stage 3 breast cancer vary, and many individuals do survive and go on to lead healthy lives after successful treatment. Survival rates are often reported as 5-year relative survival rates, which estimate the percentage of people with the same type and stage of cancer who are alive five years after diagnosis.

According to the American Cancer Society, the 5-year relative survival rate for Stage 3 breast cancer is around 72%. This statistic emphasizes that a significant proportion of individuals diagnosed with Stage 3 breast cancer survive beyond the initial five-year period.

Survival rates for Stage 3 breast cancer can vary by age and are influenced by factors such as overall health, treatment options, and individual responses to therapy. However, specific survival rates broken down by age categories may not always be readily available in general cancer statistics.

The American Cancer Society provides general survival rates for breast cancer but typically does not break down the data into age-specific categories in its public summaries

Yes, Stage 3 breast cancer indicates that the cancer has spread beyond the breast and nearby lymph nodes to surrounding tissues. In the staging of breast cancer, the extent of spread is evaluated based on factors such as tumor size, lymph node involvement, and whether the cancer has invaded nearby structures.

The American Cancer Society provides information on breast cancer staging, and Stage 3 is described as “locally advanced” cancer. This means the cancer has spread extensively in the breast or to nearby lymph nodes or tissues, but it has not yet reached distant organs.

Source: American Cancer Society.

https://www.cancer.org/content/dam/CRC/PDF/Public/8577.00.pdf

Source: National Comprehensive Cancer Network

https://www.nccn.org/patients/guidelines/content/PDF/breast-invasive-patient.pdf

Source: American Cancer Society

https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html

Source:

American Cancer Society. https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html

American Cancer Society. https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html

American Cancer Society. https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html

Source:

American Cancer Society

https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/stages-of-breast-cancer.html

Subscribe to our monthly newsletter.

Please fill out the following information to subscribe to our newsletter “Empowered: your guide to managing breast cancer with confidence” and gain access to exclusive content every month.

By clicking the “Subscribe Now” button you’re agreeing to our Terms of Service and Privacy Policy.